Amplia Therapeutics Ltd
ASX:ATX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amplia Therapeutics Ltd
ASX:ATX
|
AU |
|
WhiteHorse Finance Inc
NASDAQ:WHF
|
US |
|
BNP Paribas SA
PAR:BNP
|
FR |
|
CME Group Inc
NASDAQ:CME
|
US |
|
Domino's Pizza Inc
NASDAQ:DPZ
|
US |
|
S
|
SHAPE Australia Corp Ltd
ASX:SHA
|
AU |
|
Chong Kin Group Holdings Ltd
HKEX:1609
|
HK |
|
Goodtech ASA
OSE:GOD
|
NO |
|
1
|
1stdibs.Com Inc
NASDAQ:DIBS
|
US |
|
Powell Industries Inc
NASDAQ:POWL
|
US |
|
I
|
Italtile Ltd
JSE:ITE
|
ZA |
|
C
|
Coca-Cola Co
SWB:CCC3
|
US |
|
Synopsys Inc
MIL:1SNPS
|
US |
|
V
|
Vortex Energy Corp
CNSX:VRTX
|
CA |
|
Onespaworld Holdings Ltd
NASDAQ:OSW
|
BS |
|
eBay Inc
NASDAQ:EBAY
|
US |
Wall St Price Targets
ATX Price Targets Summary
Amplia Therapeutics Ltd
According to Wall Street analysts, the average 1-year price target for
ATX is 0.428 AUD with a low forecast of 0.424 AUD and a high forecast of 0.441 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ATX's stock price target?
Price Target
0.428
AUD
According to Wall Street analysts, the average 1-year price target for
ATX is 0.428 AUD with a low forecast of 0.424 AUD and a high forecast of 0.441 AUD.
What is the Revenue forecast for Amplia Therapeutics Ltd?
Projected CAGR
39%
Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 39%.